Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency

S. C. Pflugfelder, S. C G Tseng, J. S. Pepose, M. A. Fletcher, N. Klimas, William J Feuer

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The authors tested their hypothesis that Epstein-Barr virus (EBV) infection is a risk factor for aqueous tear deficiency (ATD) by evaluating 38 ATD patients and 17 controls for serologic evidence of EBV infection. Aqueous tear deficiency was graded clinically as mild or severe. A linear trend toward elevated EBV capsid (P < 0.05) and early antigen (P < 0.001) titers was noted from control to severe ATD patients. Rubella and cytomegalovirus antibody titers were poorly correlated with EBV titers, suggesting that the elevated EBV anti-bodies in ATD patients were not due to nonspecific polyclonal B-cell activation. Epstein-Barr virus antigens were detected in two of six lacrimal gland biopsies from severe ATD patients with Sjogren's syndrome, but in none of the control glands. Aqueous tear deficiency patients were evaluated for immunologic dysfunction associated with EBV infection. Linear trends of elevated serum IgG (P < 0.05), autoantibody and immune complex positive (P < 0.05), and reduced natural killer cell cytotoxicity (P < 0.05) were found from controls to severe ATD patients. Furthermore, reduced T-helper lymphocyte counts (P < 0.06) and an increased percentage of HLA-DR+ CD8 lymphocytes (P < 0.05) were observed in severe ATD patients compared with the mild and control groups. A multivariate analysis of the data showed a significant correlation between severe ATD and elevated EBV early antigen titers, Sjogren's syndrome, and an increased percentage of HLA-DR+ CD8 lymphocytes. The author's findings suggest that EBV infection may be a risk factor for development of ATD in a subset of ATD patients with greater disease severity, Sjogren's syndrome, and immunologic dysfunction.

Original languageEnglish
Pages (from-to)313-323
Number of pages11
JournalOphthalmology
Volume97
Issue number3
StatePublished - Jan 1 1990

Fingerprint

Epstein-Barr Virus Infections
Tears
Human Herpesvirus 4
Sjogren's Syndrome
HLA-DR Antigens
Lymphocytes
Antigens
Lacrimal Apparatus
Capsid
Lymphocyte Count
Antigen-Antibody Complex
Viral Load
Cytomegalovirus
Natural Killer Cells
Autoantibodies
B-Lymphocytes
Multivariate Analysis
Immunoglobulin G

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Pflugfelder, S. C., Tseng, S. C. G., Pepose, J. S., Fletcher, M. A., Klimas, N., & Feuer, W. J. (1990). Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency. Ophthalmology, 97(3), 313-323.

Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency. / Pflugfelder, S. C.; Tseng, S. C G; Pepose, J. S.; Fletcher, M. A.; Klimas, N.; Feuer, William J.

In: Ophthalmology, Vol. 97, No. 3, 01.01.1990, p. 313-323.

Research output: Contribution to journalArticle

Pflugfelder, SC, Tseng, SCG, Pepose, JS, Fletcher, MA, Klimas, N & Feuer, WJ 1990, 'Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency', Ophthalmology, vol. 97, no. 3, pp. 313-323.
Pflugfelder SC, Tseng SCG, Pepose JS, Fletcher MA, Klimas N, Feuer WJ. Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency. Ophthalmology. 1990 Jan 1;97(3):313-323.
Pflugfelder, S. C. ; Tseng, S. C G ; Pepose, J. S. ; Fletcher, M. A. ; Klimas, N. ; Feuer, William J. / Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency. In: Ophthalmology. 1990 ; Vol. 97, No. 3. pp. 313-323.
@article{2704e7afad1942a4bf77e37572dc17a3,
title = "Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency",
abstract = "The authors tested their hypothesis that Epstein-Barr virus (EBV) infection is a risk factor for aqueous tear deficiency (ATD) by evaluating 38 ATD patients and 17 controls for serologic evidence of EBV infection. Aqueous tear deficiency was graded clinically as mild or severe. A linear trend toward elevated EBV capsid (P < 0.05) and early antigen (P < 0.001) titers was noted from control to severe ATD patients. Rubella and cytomegalovirus antibody titers were poorly correlated with EBV titers, suggesting that the elevated EBV anti-bodies in ATD patients were not due to nonspecific polyclonal B-cell activation. Epstein-Barr virus antigens were detected in two of six lacrimal gland biopsies from severe ATD patients with Sjogren's syndrome, but in none of the control glands. Aqueous tear deficiency patients were evaluated for immunologic dysfunction associated with EBV infection. Linear trends of elevated serum IgG (P < 0.05), autoantibody and immune complex positive (P < 0.05), and reduced natural killer cell cytotoxicity (P < 0.05) were found from controls to severe ATD patients. Furthermore, reduced T-helper lymphocyte counts (P < 0.06) and an increased percentage of HLA-DR+ CD8 lymphocytes (P < 0.05) were observed in severe ATD patients compared with the mild and control groups. A multivariate analysis of the data showed a significant correlation between severe ATD and elevated EBV early antigen titers, Sjogren's syndrome, and an increased percentage of HLA-DR+ CD8 lymphocytes. The author's findings suggest that EBV infection may be a risk factor for development of ATD in a subset of ATD patients with greater disease severity, Sjogren's syndrome, and immunologic dysfunction.",
author = "Pflugfelder, {S. C.} and Tseng, {S. C G} and Pepose, {J. S.} and Fletcher, {M. A.} and N. Klimas and Feuer, {William J}",
year = "1990",
month = "1",
day = "1",
language = "English",
volume = "97",
pages = "313--323",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency

AU - Pflugfelder, S. C.

AU - Tseng, S. C G

AU - Pepose, J. S.

AU - Fletcher, M. A.

AU - Klimas, N.

AU - Feuer, William J

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The authors tested their hypothesis that Epstein-Barr virus (EBV) infection is a risk factor for aqueous tear deficiency (ATD) by evaluating 38 ATD patients and 17 controls for serologic evidence of EBV infection. Aqueous tear deficiency was graded clinically as mild or severe. A linear trend toward elevated EBV capsid (P < 0.05) and early antigen (P < 0.001) titers was noted from control to severe ATD patients. Rubella and cytomegalovirus antibody titers were poorly correlated with EBV titers, suggesting that the elevated EBV anti-bodies in ATD patients were not due to nonspecific polyclonal B-cell activation. Epstein-Barr virus antigens were detected in two of six lacrimal gland biopsies from severe ATD patients with Sjogren's syndrome, but in none of the control glands. Aqueous tear deficiency patients were evaluated for immunologic dysfunction associated with EBV infection. Linear trends of elevated serum IgG (P < 0.05), autoantibody and immune complex positive (P < 0.05), and reduced natural killer cell cytotoxicity (P < 0.05) were found from controls to severe ATD patients. Furthermore, reduced T-helper lymphocyte counts (P < 0.06) and an increased percentage of HLA-DR+ CD8 lymphocytes (P < 0.05) were observed in severe ATD patients compared with the mild and control groups. A multivariate analysis of the data showed a significant correlation between severe ATD and elevated EBV early antigen titers, Sjogren's syndrome, and an increased percentage of HLA-DR+ CD8 lymphocytes. The author's findings suggest that EBV infection may be a risk factor for development of ATD in a subset of ATD patients with greater disease severity, Sjogren's syndrome, and immunologic dysfunction.

AB - The authors tested their hypothesis that Epstein-Barr virus (EBV) infection is a risk factor for aqueous tear deficiency (ATD) by evaluating 38 ATD patients and 17 controls for serologic evidence of EBV infection. Aqueous tear deficiency was graded clinically as mild or severe. A linear trend toward elevated EBV capsid (P < 0.05) and early antigen (P < 0.001) titers was noted from control to severe ATD patients. Rubella and cytomegalovirus antibody titers were poorly correlated with EBV titers, suggesting that the elevated EBV anti-bodies in ATD patients were not due to nonspecific polyclonal B-cell activation. Epstein-Barr virus antigens were detected in two of six lacrimal gland biopsies from severe ATD patients with Sjogren's syndrome, but in none of the control glands. Aqueous tear deficiency patients were evaluated for immunologic dysfunction associated with EBV infection. Linear trends of elevated serum IgG (P < 0.05), autoantibody and immune complex positive (P < 0.05), and reduced natural killer cell cytotoxicity (P < 0.05) were found from controls to severe ATD patients. Furthermore, reduced T-helper lymphocyte counts (P < 0.06) and an increased percentage of HLA-DR+ CD8 lymphocytes (P < 0.05) were observed in severe ATD patients compared with the mild and control groups. A multivariate analysis of the data showed a significant correlation between severe ATD and elevated EBV early antigen titers, Sjogren's syndrome, and an increased percentage of HLA-DR+ CD8 lymphocytes. The author's findings suggest that EBV infection may be a risk factor for development of ATD in a subset of ATD patients with greater disease severity, Sjogren's syndrome, and immunologic dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0025241812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025241812&partnerID=8YFLogxK

M3 - Article

C2 - 2159609

AN - SCOPUS:0025241812

VL - 97

SP - 313

EP - 323

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 3

ER -